Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Operating Expenses (2018 - 2025)

Historic Operating Expenses for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $5.8 million.

  • Dna X's Operating Expenses fell 1228.81% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year increase of 5351.8%. This contributed to the annual value of $43.6 million for FY2024, which is 13156.13% up from last year.
  • Latest data reveals that Dna X reported Operating Expenses of $5.8 million as of Q3 2025, which was down 1228.81% from $7.6 million recorded in Q2 2025.
  • Dna X's Operating Expenses' 5-year high stood at $21.9 million during Q4 2024, with a 5-year trough of $3.7 million in Q2 2023.
  • Moreover, its 5-year median value for Operating Expenses was $7.1 million (2022), whereas its average is $8.1 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first tumbled by 5806.35% in 2022, then surged by 24385.88% in 2024.
  • Quarter analysis of 5 years shows Dna X's Operating Expenses stood at $11.3 million in 2021, then crashed by 55.66% to $5.0 million in 2022, then grew by 27.73% to $6.4 million in 2023, then skyrocketed by 243.86% to $21.9 million in 2024, then plummeted by 73.56% to $5.8 million in 2025.
  • Its last three reported values are $5.8 million in Q3 2025, $7.6 million for Q2 2025, and $7.7 million during Q1 2025.